Zell Early-Stage Fund
Real Investing. Real Startups. Real Impact.
As a member of the Zell Early-Stage Fund, you’ll evaluate and diligence real startups, work directly with founders to see bold ideas turn into businesses, and invest real capital from the University’s endowment. Along the way, you’ll earn three credits each winter of your junior and senior year, and learn from Professor Gordon, a seasoned investor who will challenge you to sharpen your skills, expand your limits, and build the confidence to excel in any career.
We are seeking current BBA and engineering sophomores who will be on campus during their Junior Winter semester. Prior venture capital experience is not required.
Our Investment in Admetsys
ZESF invested $150,000 in Admetsys, a medical device company that has
developed an artificial pancreas to help monitor insulin levels for hospital and
surgical care. Admetsys helps minimize hospital complications and reduce ICU stay
time, and save lives with quick glycemic measurements and calculated insulin
administration.
If you’re a startup interested in partnering with us, reach out at [email protected]— we’d love to hear from you.
Fund Members
Brian Fang
Managing Director
Chrishan Villavarayan
Managing Director
Matthew Nyaanga
Recruitment Chair
Rebekah Cheong
External Chair
Benjamin Chin
External Chair
Brendan Pawlicki
External Chair
Eudora Chi
Deal Team Head
Ana Liu
Deal Team Head
Daniel Espinoza
Deal Team Head
Manish Ileni
Deal Team Head
Elliott Nederhood
Deal Team Head
Karen Vera Sanchez
Deal Team Head
Charles Sebestyen
Junior Analyst
Aaryana Parekh
Junior Analyst
Ramu Kannan
Junior Analyst
Vincent Koutras
Junior Analyst
Rebecca Hsieh
Junior Analyst
Tejas Maroju
Junior Analyst
